FDA examines use of testosterone prescriptions for menopause

Specialists at an FDA public workshop cautioned on Thursday that key questions about testosterone therapy’s long-term safety remain unanswered. 

​Specialists at an FDA public workshop cautioned on Thursday that key questions about testosterone therapy’s long-term safety remain unanswered.   Health Specialists at an FDA public workshop cautioned on Thursday that key questions about testosterone therapy’s long-term safety remain unanswered.